LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and GSK The company operates at…
New research has uncovered a shared biological weakness running across three distinct pediatric brain cancers, a finding that opens a realistic path…
LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients…
Ongoing digital monitoring could be about to solve one of modern medicine's most frustrating access problems. Life-extending cancer immunotherapies exist and…
Frontieras’ patent portfolio includes protection across five continents and nine countries, covering approximately 85% of global coal production. The FASForm(TM)…
AI data centers are rapidly increasing electricity consumption, creating new and significant pressures on America’s power infrastructure, with analysts warning…
The promise of immunotherapy lies in its ability to harness the body’s own immune defenses to recognize and destroy malignant…
GridAI Technologies (NASDAQ: GRDX) announced that Amp Z has been identified as the previously disclosed stealth-mode hyperscale artificial intelligence data center developer…
Reports indicate the U.S. military wasstill running Anthropic's AI models during strikes on Iran even after President Trump had formally…
A new study may have just given brain surgeons a significantly better way to fight cancer without compromising how patients live afterward. Published…